Affordable Access

deepdyve-link
Publisher Website

[Choice of new drugs in castration-resistant prostate cancer: predictive factors and effectiveness assessment].

Authors
  • Basset, V
  • Flamand, V
  • Crouzet, S
  • Ploussard, G
Type
Published Article
Journal
Progrès en Urologie
Publisher
Elsevier
Publication Date
Oct 01, 2013
Volume
23 Suppl 1
Identifiers
DOI: 10.1016/S1166-7087(13)70045-9
PMID: 24314738
Source
Medline
Keywords
License
Unknown

Abstract

Although new molecules have recently become available, the experience with their use is limited. Thus, no predictive markers of response rates and treatment outcomes or data concerning the best treatment sequence to use in patients with CRPC are as yet available.

Report this publication

Statistics

Seen <100 times